Simcere Holding Limited and Simcere Acquisition Limited to Acquire Simcere Pharmaceutical Group for $4.83/Share or $9.66/ADS
August 28, 2013 at 06:02 AM EDT
Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR ), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, announced today that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with Simcere Holding
